India Genetic Testing Market to Grow with a CAGR of 6.89% through 2030
Increasing prevalence of genetic disorders and chronic
diseases is expected to drive the India Genetic Testing Market growth in the
forecast period, 2026-2030.
According to
TechSci Research report, “India Genetic Testing Market- Industry Size,
Share, Trends, Competition Forecast & Opportunities, 2030F”, the India
Genetic Testing Market stood at USD
69.24 Million in 2024 and is anticipated to grow with a CAGR of 6.89%
in the forecast period through 2030.
As of
recent times, the India Genetic Testing Market has been experiencing
significant growth and evolution, driven by various factors such as technological
advancements, increasing awareness about genetic disorders, expanding
healthcare infrastructure, and a growing focus on personalized medicine. The
market encompasses a wide range of genetic testing services, including
diagnostic testing for inherited diseases, prenatal screening, cancer genetics,
pharmacogenomics, ancestry testing, and predictive/preventive testing.
One
of the key drivers of the India Genetic Testing Market is the increasing
prevalence of genetic disorders and chronic diseases in the population. Genetic
testing plays a crucial role in the early detection, diagnosis, and management
of these conditions, enabling healthcare providers to tailor treatment plans
and interventions according to individual genetic profiles. Advancements in
technology, such as next-generation sequencing (NGS), polymerase chain reaction
(PCR), and microarray analysis, have revolutionized genetic testing
methodologies, making them more accurate, efficient, and cost-effective.
The
India Genetic Testing Market is also witnessing a growing emphasis on
preventive healthcare and personalized medicine, fueled by advancements in
genomic research and understanding of the genetic basis of diseases. Genetic
testing allows for the identification of individuals at increased risk of
developing certain diseases, enabling early intervention, lifestyle
modifications, and targeted screening programs to prevent or mitigate disease
progression. The integration of genetic testing with electronic health records
(EHRs) and digital health platforms is facilitating the delivery of
personalized healthcare solutions and improving patient outcomes.
In
recent years, there has been a notable increase in the adoption of genetic
testing services across various healthcare settings, including hospitals,
diagnostic laboratories, academic medical centers, and specialty clinics. This
surge in demand for genetic testing is driven by factors such as rising
healthcare expenditure, growing patient awareness, and expanding insurance
coverage for genetic testing services. Government initiatives and
public-private partnerships aimed at promoting genetic testing awareness,
capacity building, and research are contributing to market growth and
accessibility.
However,
the India Genetic Testing Market also faces several challenges and barriers to
growth, including the high cost of testing, limited access to genetic
counseling services, regulatory and quality assurance concerns, ethical and
social implications, and disparities in healthcare access between urban and
rural areas. Addressing these challenges will require concerted efforts from
policymakers, healthcare providers, industry stakeholders, and regulatory
authorities to ensure the safe, effective, and equitable delivery of genetic
testing services to all segments of the population.
Looking
ahead, the India Genetic Testing Market is poised for continued growth and
innovation, driven by advancements in technology, expanding clinical
applications, and increasing adoption of personalized medicine approaches. As
genomic medicine continues to transform healthcare delivery and improve patient
outcomes, genetic testing is expected to play an increasingly prominent role in
disease prevention, diagnosis, and treatment decision-making in India and
beyond. With ongoing investments in research, infrastructure, and education,
the genetic testing market holds immense potential to address unmet medical
needs, enhance healthcare quality, and empower individuals to make informed
health choices based on their genetic information.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India Genetic Testing Market”
India Genetic
Testing Market is segmented into type, application, regional distribution, and
company.
Based on application,
predictive and pre-symptomatic Testing emerges as the second dominant segment
in the India Genetic Testing Market. This category encompasses genetic tests
designed to predict an individual's risk of developing certain diseases or
conditions before symptoms appear, allowing for early intervention, prevention,
and personalized healthcare management. Predictive and pre-symptomatic testing
holds significant clinical relevance and utility across various medical
specialties, including oncology, cardiology, neurology, and rare diseases.
In the realm of
oncology, predictive testing plays a critical role in identifying individuals
at increased risk of developing hereditary cancer syndromes, such as hereditary
breast and ovarian cancer (HBOC) syndrome, Lynch syndrome, and familial
adenomatous polyposis (FAP). These genetic tests assess the presence of
specific mutations or genetic variants associated with an elevated risk of
developing certain cancers, enabling targeted screening, risk-reducing
interventions, and personalized treatment strategies. For example, individuals
with a positive BRCA1 or BRCA2 mutation result from predictive testing may opt
for risk-reducing surgeries, such as prophylactic mastectomy or oophorectomy,
to reduce their risk of developing breast or ovarian cancer. In addition to
oncology, predictive and pre-symptomatic testing is increasingly being utilized
in other disease areas, such as cardiology, to assess an individual's genetic
predisposition to cardiovascular conditions, including familial
hypercholesterolemia, hypertrophic cardiomyopathy, and long QT syndrome.
Genetic testing for inherited cardiac conditions enables early identification
of at-risk individuals, implementation of preventive measures, such as
lifestyle modifications and medication therapy, and screening of family members
to prevent adverse cardiac events.
Based on region,
South India emerges as second dominating region in the India Genetic Testing
Market. South India, comprising states like Karnataka, Tamil Nadu, Telangana,
Andhra Pradesh, and Kerala, boasts a robust healthcare ecosystem characterized
by world-class hospitals, research institutions, and biotechnology hubs. Cities
such as Bengaluru, Chennai, and Hyderabad serve as epicenters of medical innovation
and genetic testing services in the region.
Bengaluru, often
referred to as India's Silicon Valley, is renowned for its thriving biotech
industry and academic research institutes focused on genomics and personalized
medicine. The city hosts leading hospitals, diagnostic laboratories, and
biotech startups, driving advancements in genetic testing technologies and
clinical applications. Chennai, the capital city of Tamil Nadu, is home to
premier medical institutions, research centers, and specialty clinics offering
state-of-the-art genetic testing services across various medical specialties. Hyderabad,
the capital city of Telangana, has emerged as a major biotech hub in South
India, attracting investments from global pharmaceutical companies and
fostering collaborations in genomic research and drug discovery. The presence
of research institutions, biotechnology parks, and academic-industry
partnerships in Hyderabad accelerates innovation in genetic testing and
personalized medicine. Cities like Kochi in Kerala and Vijayawada in Andhra
Pradesh are witnessing growing interest and investment in genetic testing
services, driven by increasing healthcare awareness and infrastructure
development.
Major companies
operating in India Genetic Testing Market are:
- MedGenome Labs Limited
- Strand Life Sciences Pvt Ltd.
- Centogene India Private Limited
- Eurofins Genomics India Pvt Ltd.
- Mapmygenome India Limited
- Clevergene Biocorp Private Limited
- LifeCell International Pvt. Ltd.
- Genes2Me Pvt. Ltd.
- GeneTech India Private Limited
- DNA Forensics Laboratory Pvt. Ltd.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the India Genetic Testing Market holds immense promise and potential, driven by
advancements in technology, expanding clinical applications, and increasing
awareness about personalized medicine. With ongoing investments in genomic
research, infrastructure, and healthcare delivery, genetic testing is poised to
become increasingly accessible, affordable, and integrated into routine
clinical practice across the country. The adoption of digital health platforms,
telemedicine, and artificial intelligence (AI) technologies will further
enhance the delivery and interpretation of genetic testing services, enabling
more precise risk prediction, disease diagnosis, and personalized treatment
strategies. As genomic medicine continues to evolve, genetic testing will play
an instrumental role in disease prevention, early detection, and precision
medicine initiatives, ultimately improving health outcomes and quality of life
for individuals in India.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“India Genetic Testing Market By Type (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Reproductive Cancer Screening, Ancestry Testing, Predictive and Pre-symptomatic Testing, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Genetic
Testing Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in India Genetic Testing
Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com